Newsquawk Logo

US PRE-MARKET MOVERS: COF, SYF, JPM, C, MRNA, UNH, DUOL, EXEL, SHAK, SNCY, ALGT, PLTR, CRWD, SNOW

In the pre-market, several notable stocks are experiencing significant movements.

Newsquawk StaffPublished On the live feed at — 5 more headlines followed before this page went public
Newsquawk headlinesUTC

German Finance Minister says price floors for rare earths is an option they will discuss at G7

German Finance Minister on Trump's Fed attack says central bank independence is a clear line for him as a finance minister

US PRE-MARKET MOVERS: COF, SYF, JPM, C, MRNA, UNH, DUOL, EXEL, SHAK, SNCY, ALGT, PLTR, CRWD, SNOW

NATO's Rutte says he believes US President Trump is doing the right thing for NATO

President Trump will interview BlackRock's (BLK) Rick Rieder this week to possibly be next Fed Chair, FOX Business reports citing sources; sources say it will take place on Thursday

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.

ES -0.5%, NQ -0.7%, RTY -0.2%

  • COF -8.2%, SYF -9.6%, JPM -2.4%, C -4.1%: Trump is calling for a one-year cap on credit card interest rates of 10%.
  • MRNA +2.1%: 2025 rev. outlook matched the street view.
  • UNH -1.0%: Reportedly used aggressive tactics when collecting payment-boosting diagnoses for Medicaid Advantage members.
  • DUOL -4.3%: Announced CFO transition; prelim Q4 results disappoint.
  • EXEL -4.7%: FY26 rev. view missed expectations.
  • SHAK -2.8%: Prelim Q4 rev. metric missed expectations.
  • SNCY +14.0%: ALGT, -3.1%, to acquire SNCY for 18.89/shr.
  • PLTR +0.6%: Upgraded at Citi to 'Buy' from 'Neutral'.
  • CRWD -2.2%: Downgraded at KeyBanc to 'Sector Weight' from 'Overweight'.
  • SNOW -2.2%: Downgraded at Barclays to 'Equal Weight' from 'Overweight'.
Context

Notably, financials like Capital One and Synchrony are down sharply due to proposed policy changes regarding credit card interest rates. Conversely, Moderna is climbing slightly after meeting street expectations in its revenue outlook, suggesting some resilience in biotech, though overall sentiment appears mixed with several downgrades impacting tech shares like CrowdStrike and Snowflake.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.